Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

The B7 family revisited.

Greenwald RJ, Freeman GJ, Sharpe AH.

Annu Rev Immunol. 2005;23:515-48. Review.

PMID:
15771580
2.

Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.

Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H Jr, Sayegh MH, Najafian N.

J Immunol. 2005 Jun 1;174(11):6648-56.

3.

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.

Salomon B, Bluestone JA.

Annu Rev Immunol. 2001;19:225-52. Review.

PMID:
11244036
4.

The B7-CD28 superfamily.

Sharpe AH, Freeman GJ.

Nat Rev Immunol. 2002 Feb;2(2):116-26. Review.

PMID:
11910893
5.

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.

Carreno BM, Collins M.

Annu Rev Immunol. 2002;20:29-53. Epub 2001 Oct 4. Review.

PMID:
11861596
6.
7.

B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.

Liu Z, Geboes K, Hellings P, Maerten P, Heremans H, Vandenberghe P, Boon L, van Kooten P, Rutgeerts P, Ceuppens JL.

J Immunol. 2001 Aug 1;167(3):1830-8.

8.

Targeting T cell costimulation in autoimmune disease.

Stuart RW, Racke MK.

Expert Opin Ther Targets. 2002 Jun;6(3):275-89. Review.

PMID:
12223069
9.

ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.

Witsch EJ, Peiser M, Hutloff A, B├╝chner K, Dorner BG, Jonuleit H, Mages HW, Kroczek RA.

Eur J Immunol. 2002 Sep;32(9):2680-6.

10.

The expanding world of co-stimulation: the two-signal model revisited.

Chambers CA.

Trends Immunol. 2001 Apr;22(4):217-23. Review.

PMID:
11274928
11.
12.

The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function.

Coyle AJ, Gutierrez-Ramos JC.

Nat Immunol. 2001 Mar;2(3):203-9. Review.

PMID:
11224518
13.

Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.

Li J, Semple K, Suh WK, Liu C, Chen F, Blazar BR, Yu XZ.

Biol Blood Marrow Transplant. 2011 Jul;17(7):962-9. doi: 10.1016/j.bbmt.2011.01.018. Epub 2011 Mar 27.

14.

Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.

Fife BT, Bluestone JA.

Immunol Rev. 2008 Aug;224:166-82. doi: 10.1111/j.1600-065X.2008.00662.x. Review.

PMID:
18759926
15.
16.

Negative co-receptors on lymphocytes.

Greenwald RJ, Latchman YE, Sharpe AH.

Curr Opin Immunol. 2002 Jun;14(3):391-6. Review.

PMID:
11973140
17.

CD28/CTLA-4 and CD80/CD86 families: signaling and function.

Slavik JM, Hutchcroft JE, Bierer BE.

Immunol Res. 1999;19(1):1-24. Review.

PMID:
10374692
18.

CD28/B7 costimulation: a review.

Greenfield EA, Nguyen KA, Kuchroo VK.

Crit Rev Immunol. 1998;18(5):389-418. Review.

PMID:
9784967
19.

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA.

Immunity. 2000 Apr;12(4):431-40.

Supplemental Content

Support Center